Cardiac Imaging in FIP1L1-PDGFRA  by Jaworski, Catherine et al.
From the *Department of
Cardiovascular Medicine,
Alfred Hospital, Melbourne,
Australia; yDepartment of
Haematology, Alfred Hospital,
Melbourne, Australia; and
the zBaker IDI Heart and
Diabetes Research Institute,
Melbourne, Australia.
Manuscript received
April 8, 2013;
accepted April 9, 2013.
Journal of the American College of Cardiology Vol. 62, No. 14, 2013
 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.04.099IMAGES IN CARDIOLOGY
Cardiac Imaging in FIP1L1-PDGFRA
Catherine Jaworski, MBBS,* Jen-Li Looi, MBCHB,* Joshua Martin, MBCHB,* Peter Bergin, MBBS,*
James Hare, MBBS, PHD,* David Kaye, MBBS, PHD,* Andrew Wei, MBBS, PHD,y
Andrew J. Taylor, MBBS, PHD*z
Melbourne, AustraliaIP1L1-PDGFRA is a recently discovered rare cause of primary hypereosinophilia,Fclassiﬁed as myeloid and lymphoid neoplasm (1). One-third of patients may have cardiacinvolvement manifesting as heart failure or left ventricular thrombus (1), commonly leading
to a misdiagnosis of apical hypertrophic cardiomyopathy.
A 50-year-old man presented with acute pulmonary edema and eosinophilia. Transthoracic
echocardiographic results were suspicious for apical hypertrophic cardiomyopathy (A, arrows).
Cardiac magnetic resonance imaging demonstrated a homogenous mass (arrows) within the left
ventricle (B, Online Video 1). Late gadolinium enhancement imaging demonstrated a non-
enhancing left ventricular mass, consistent with extensive thrombus (C, red asterisk). There was
thin subendocardial late gadolinium enhancement (arrows), subtending the thrombus distribution,
pathognomonic for subendocardial ﬁbrosis. Endomyocardial biopsy showed eosinophils
(D, arrows) and endocardial ﬁbrosis (E, arrows). Bone marrow aspirate demonstrated marked
eosinophilia (F), conﬁrming FIP1L1-PDGFRA.
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